Cornerstone Capital’s Celgene Corp CELG Stock Holding History

Cornerstone Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,800	Closed	-$251K	–	83
2018 Q3	$251K	Hold	2,800	–	–	0.04%	71
2018 Q2	$222K	Hold	2,800	–	–	0.04%	72
2018 Q1	$250K	Hold	2,800	–	–	0.04%	76
2017 Q4	$292K	Hold	2,800	–	–	0.05%	72
2017 Q3	$408K	Hold	2,800	–	–	0.07%	63
2017 Q2	$364K	Hold	2,800	–	–	0.07%	65
2017 Q1	$348K	Hold	2,800	–	–	0.07%	65
2016 Q4	$324K	Hold	2,800	–	–	0.07%	68
2016 Q3	$293K	Hold	2,800	–	–	0.06%	64
2016 Q2	$276K	Hold	2,800	–	–	0.06%	64
2016 Q1	$280K	Hold	2,800	–	–	0.06%	64
2015 Q4	$335K	Hold	2,800	–	–	0.08%	61
2015 Q3	$303K	Hold	2,800	–	–	0.08%	66
2015 Q2	$324K	Hold	2,800	–	–	0.07%	67
2015 Q1	$323K	Hold	2,800	–	–	0.08%	55
2014 Q4	$313K	Hold	2,800	–	–	0.08%	56
2014 Q3	$265K	Hold	2,800	–	–	0.07%	62
2014 Q2	$240K	Sell	2,800 -300	-10%	-$22.8K	0.06%	61
2014 Q1	$216K	Hold	3,100	–	–	0.06%	63
2013 Q4	$262K	Hold	3,100	–	–	0.08%	62
2013 Q3	$239K	Buy	+3,100	New	+$217K	0.07%	63

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cornerstone Capital's CELG Position: Q4 2018 in Review

Cornerstone Capital sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,800 shares — an estimated $251K sold.

Cornerstone Capital first reported a position in CELG in Q3 2013 and held it in 21 quarters. The position peaked at $408K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Cornerstone Capital reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Cornerstone Capital sold 2,800 Celgene Corp shares in Q4 2018, an estimated $251K.
Cornerstone Capital first reported a position in Celgene Corp in Q3 2013 and held it in 21 quarters.
Cornerstone Capital's Celgene Corp position peaked at $408K in Q3 2017.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Cornerstone Capital's 13F filing for Q4 2018, filed 11 Feb 2019.